5Department of Hepatobiliary & Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 6NHC Key Laboratory of Combined Multi-Organ Transplantation, ...

The mixed results are a blow for bepranemab and for related antibodies that target a mid-region epitope on tau. But exploratory analyses of the results hint at a path forward for these candidates.

The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. The company was spun ...

Ueda is holding an expandable toy that he uses to demonstrate how the company’s computationally designed Antibody Cages work. (GeekWire Photo / Alan Boyle) Three weeks after University of ...

Therapeutic antibodies are an important alternative option, but resistance has developed owing to the emergence of viral variants. A new paper in Cell reports the development of an antibody with ...

Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 465-8603, Japan Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural ...

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

About clesrovimab (MK-1654) Clesrovimab (MK-1654) is an investigational, extended half-life monoclonal antibody (mAb) developed as a passive immunization for the prevention of RSV. Clesrovimab is ...

CX3CR1+ resident and CCR2+ recruited cells sorted from the hypothalamus of HFD-fed ... For that, we performed icv injections of an immunoneutralizing antibody, which resulted in smaller numbers of ...

This study is valuable and contains results that are supported by convincing evidence. In the future, the observations could be further strengthened by independent validation, and by looking at larger ...

This is because some drugs work in more than one way and belong to more than one group. Checkpoint inhibitors are also described as a type of monoclonal antibody or targeted treatment. Our immune ...